Companion Diagnostic Test Kit - KRAS Mutation Detection

In vitro diagnostic kit for detecting KRAS gene mutations in patient samples. Enables rapid molecular identification of KRAS mutations for oncology treatment planning and patient stratification. Supports precision medicine approaches in cancer care.

A diagnostic assay for detection of KRAS mutations in colorectal and other cancers using PNA-based technology for precision medicine applications.

A molecular diagnostic kit designed for the detection of C-KIT mutations. Used in oncology and haematology applications for identifying specific genetic mutations associated with various malignancies.

This kit is intended for in vitro qualitative detection of 8 mutations in codons 12 and 13 of K-ras gene in extracted DNA from human paraffin-embedded pathological sections.

PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.

A molecular diagnostic kit for PIK3CA mutation detection. Used in solid tumour oncology for identifying phosphatidylinositol 3-kinase gene mutations in patient samples.

PCR-based kits designed to detect specific gene mutations and polymorphisms associated with malignancy. These products enable targeted molecular analysis for precision tumor diagnosis.

Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.

In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.

Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.

A molecular diagnostic kit for CXCR4 mutation detection. Utilized in haematology and oncology for identifying CXCR4 gene mutations in patient samples.